Vanda Pharmaceuticals Releases Financial Results Announcement
Vanda Pharmaceuticals to Release Q2 Financial Results
Vanda Pharmaceuticals Inc. has exciting news regarding its upcoming financial results for the second quarter of 2025. This prominent biopharmaceutical company, listed on Nasdaq under the ticker VNDA, is set to announce its results on an anticipated date. Before the market opens, investors can look forward to understanding how the company has performed during the period.
Conference Call Details
On the important day of the announcement, Vanda will follow up with a conference call at 8:00 AM ET. This call will provide a platform for the management team to delve into the financial results and share insights into the company’s ongoing efforts and future strategies. It's an opportunity for stakeholders to connect and ask questions related to the company’s performance and plans.
How to Join the Conference Call
Participants wishing to join the conference call can do so by dialing 1-800-715-9871 for domestic calls or 1-646-307-1963 for international listeners. It’s essential for callers to use the designated passcode: 9430387, to ensure a smooth and organized call experience.
Replay Availability
For those unable to attend the live call, a replay will be made available shortly after the call ends. From 11:00 AM ET on the same day, listeners can access the replay until a week later at 11:59 PM ET. The replay will be available by calling 1-800-770-2030 for domestic callers and 1-609-800-9909 for international calls, with the same passcode of 9430387 required to listen in.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals is committed to innovating therapies that tackle high unmet medical needs. As a global leader in biopharmaceuticals, Vanda focuses on enhancing the quality of life for patients across various healthcare challenges. For anyone wishing to learn more about the company’s mission and initiatives, visiting their website is highly encouraged. They also maintain active engagement on social platforms, such as X, under the handle @vandapharma.
Contact Information
For further inquiries, you can reach out to Vanda’s corporate contact, Kevin Moran, who serves as the Senior Vice President, Chief Financial Officer, and Treasurer. He is ready to assist with any questions regarding the company's financial outlook and strategic positioning. You can also explore the insights of collected strategies from team members Jim Golden, Jack Kelleher, and Dan Moore, who regularly provide valuable perspectives on the company's progress.
Frequently Asked Questions
When will Vanda Pharmaceuticals announce its second quarter results?
Vanda Pharmaceuticals will announce its second quarter financial results on July 31, 2025.
How can I participate in the conference call?
To participate, call 1-800-715-9871 or 1-646-307-1963 and use the passcode 9430387.
Is there a way to access a replay of the conference call?
Yes, the replay will be available from 11:00 AM ET on July 31 to August 7, 2025, using the same call-in numbers and passcode.
What is Vanda's main focus as a biopharmaceutical company?
Vanda Pharmaceuticals focuses on developing innovative therapies to address high unmet medical needs and improve patient lives.
Who should I contact for more information about Vanda Pharmaceuticals?
You can contact Kevin Moran, the Senior Vice President and CFO, for detailed inquiries about the company.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
